Wordt geladen...
Synergism of Heat Shock Protein 90 and Histone Deacetylase Inhibitors in Synovial Sarcoma
Current systemic therapies have little curative benefit for synovial sarcoma. Histone deacetylase (HDAC) inhibitors and the heat shock protein 90 (Hsp90) inhibitor 17-AAG have recently been shown to inhibit synovial sarcoma in preclinical models. We tested combinations of 17-AAG with the HDAC inhibi...
Bewaard in:
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Hindawi Publishing Corporation
2009
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2659882/ https://ncbi.nlm.nih.gov/pubmed/19325926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/794901 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|